Makers Laboratories (506919) Stock Overview
An integrated pharmaceutical company, manufactures and markets formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
506919 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Makers Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹151.95 |
| 52 Week High | ₹173.70 |
| 52 Week Low | ₹109.00 |
| Beta | -0.11 |
| 1 Month Change | 7.69% |
| 3 Month Change | 30.43% |
| 1 Year Change | 16.93% |
| 3 Year Change | 50.37% |
| 5 Year Change | -39.07% |
| Change since IPO | 322.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506919 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.7% | 2.6% | 1.1% |
| 1Y | 16.9% | 2.2% | -0.9% |
Return vs Industry: 506919 exceeded the Indian Pharmaceuticals industry which returned 2.1% over the past year.
Return vs Market: 506919 exceeded the Indian Market which returned -0.2% over the past year.
Price Volatility
| 506919 volatility | |
|---|---|
| 506919 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 506919's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 506919's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 131 | Saahil Parikh | www.makerslabs.com |
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid.
Makers Laboratories Limited Fundamentals Summary
| 506919 fundamental statistics | |
|---|---|
| Market cap | ₹896.56m |
| Earnings (TTM) | ₹12.13m |
| Revenue (TTM) | ₹1.39b |
Is 506919 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506919 income statement (TTM) | |
|---|---|
| Revenue | ₹1.39b |
| Cost of Revenue | ₹672.11m |
| Gross Profit | ₹715.35m |
| Other Expenses | ₹703.22m |
| Earnings | ₹12.13m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.05 |
| Gross Margin | 51.56% |
| Net Profit Margin | 0.87% |
| Debt/Equity Ratio | 6.8% |
How did 506919 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/26 06:48 |
| End of Day Share Price | 2026/03/25 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Makers Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |